Brady James Aloysius

Insider profile

Brady James Aloysius's trades of Xeris Biopharma Holdings Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-01 2026-03-30 PlS Planned sale
21,651 -35.5%
481.62
US$2,483,875
21,651 -35.5% 481.62 US$2,483,875
2026-03-30 2026-03-30 PrS Proposed sale
70,132
472.83
US$3,185,605
70,132 472.83 US$3,185,605
2025-08-05 2025-08-01 S Sale
59,052 +42.0%
270.60
US$2,636,770
59,052 +42.0% 270.60 US$2,636,770